🔗 Share this article

The prestigious award in medical science was awarded for revolutionary discoveries that illuminate how the immune system targets dangerous infections while sparing the body's own cells.

Three esteemed scientists—from Japan Shimon Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this honor.

Their research uncovered unique "sentinels" within the defense system that remove rogue immune cells that could harming the organism.

These discoveries are now paving the way for innovative therapies for immune disorders and cancer.

The winners will share a prize fund worth 11 million Swedish kronor.

Crucial Findings

"The research has been decisive for comprehending how the body's defenses operates and the reason we do not all develop severe autoimmune diseases," commented the chair of the Nobel Committee.

This team's studies explain a fundamental question: How does the defense system protect us from numerous invaders while keeping our healthy cells unharmed?

Our immune system uses white blood cells that search for indicators of disease, including viruses and bacteria it has not met before.

Such defenders employ detectors—known as receptors—that are generated by chance in a vast number of variations.

This gives the immune system the capacity to combat a wide array of invaders, but the unpredictability of the mechanism unavoidably produces immune cells that can target the body.

Protectors of the Body

Scientists earlier understood that a portion of these problematic defense cells were eliminated in the immune organ—where immune cells develop.

The latest award recognizes the identification of T-reg cells—described as the body's "security guards"—which travel through the system to neutralize any defenders that attack the body's own tissues.

We know that this mechanism fails in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and RA.

The prize committee added, "The discoveries have established a new field of investigation and accelerated the creation of new treatments, for example for tumors and autoimmune diseases."

Regarding cancer, T-regs block the system from fighting the growth, so studies are aimed at reducing their quantity.

For self-attack disorders, trials are exploring increasing T-reg cells so the body is no longer being harmed. A comparable approach could also be useful in reducing the risks of organ transplant rejection.

Pioneering Studies

Professor Shimon Sakaguchi, of Osaka University, conducted experiments on rodents that had their thymus removed, causing autoimmune disease.

He demonstrated that injecting immune cells from other mice could prevent the disease—suggesting there was a mechanism for preventing immune cells from attacking the host.

Mary Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an genetic immune disorder in mice and humans that resulted in the discovery of a gene critical for the way regulatory T-cells operate.

"Their groundbreaking research has uncovered how the body's defenses is controlled by T-reg cells, preventing it from accidentally attacking the healthy cells," commented a prominent biological science specialist.

"This work is a remarkable illustration of how fundamental physiological research can have far-reaching implications for public health."